On June 4, Oscar Health rose 5.55% in pre-market trading, trading at $21.59/share, with trading volume of $1.97 million.

On the news front, Wells Fargo upgraded Oscar Health from Underweight to Equal Weight, significantly raising its price target from $11 to $20. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean price target of $22.18. The upgrade signals a materially improved outlook from one of the major investment banks that had previously maintained a bearish stance on the stock.

The positive catalyst helped offset negative sentiment from earlier in the week, when Oscar Health declined over 5% on June 2 following the announcement that co-founder and Chief Technology Officer Mario Schlosser stepped down from his CTO role to transition into an advisory position while remaining on the board. As a technology-driven health insurance platform, the executive change had raised concerns about strategic continuity. Wells Fargo's upgraded view appears to have provided a counterbalance, driving the pre-market rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)